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The study investigated the extent to which defensive functioning and defense
mechanisms predict clinically meaningful symptomatic improvement within brief
psychodynamic psychotherapy for recurrent and chronic depression in an inpatient
setting. Treatment response was defined as a reduction in symptom severity of 46%
or higher from the baseline score on the Montgomery–Asberg Depression Rating
Scale (MADRS). A subsample of 41 patients (19 responders and 22 non-responders)
from an RCT was included. For each case, two sessions (the second and the
penultimate) of brief inpatient psychodynamic psychotherapy (a manualized 12-session
therapy program developed in Lausanne) were transcribed and then coded using the
Defense Mechanism Rating Scales (DMRS) and the Psychotic Defense Mechanism
Rating Scales (P-DMRS), an additional scale developed to study psychotic defenses.
Results showed that defensive functioning and mature and immature defense changed
during psychotherapy and predicted treatment response. Patient’s defenses observed
throughout therapy also predicted treatment response at 12-month follow-up. The
addition of psychotic defenses allows a better prediction of the treatment response.
Overall, these results are in line with previous research and provide further validation
of defensive functioning as a predictor of outcomes and a mechanism of change
in psychotherapy.
Keywords: defense, depression, treatment response, inpatient, psychodynamic psychotherapy, brief
psychotherapy, psychotic defense
INTRODUCTION
From an empirical perspective, psychological defenses might be viewed either as a patient trait that
determines the course and outcome of treatment, as a therapeutic outcome that evolves toward
more adaptability, or as an underlying mechanism of change that explains how psychotherapy
works from the psychodynamic theoretical perspective.
Studies have suggested that defenses can be associated with depression. Compared to a healthy
control group, depressed individuals were found to use significantly more maladaptive and
fewer adaptive defense mechanisms at baseline (Vaillant, 1986). DeFife and Hilsenroth (2005)
showed that the presence and severity of depression symptoms were significantly related to lower
(more maladaptive) overall defensive functioning (ODF) scores. In addition, patients who lack
obsessional defenses of mental inhibition (including isolation, undoing, and intellectualization)
are more severely depressed. Compared to panic disorder, Calati et al.’s (2010) meta-analysis
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confirmed a specific defensive profile related to depression,
characterized by a low level of mature and a high level of
immature defenses.
A group of eight immature defenses, called depressive defenses
(help-rejecting complaining, acting out, splitting of self-image,
splitting of others’ images, projective identification, devaluation
of self-image, devaluation of others’ images, and projection),
hypothesized to play a causal role in depression, were found
to predict the course of major depression in a sample of
psychiatric patients. Six months after intake, immature defenses
were identified more often in depressed patients who improved
less than predicted by their initial functional status and one
high adaptive level defense (self-observation) was identified
more often in those who improved more than predicted by
their initial status (Hoglend and Perry, 1998). These depressive
defenses were associated with lower patient improvement on
global functioning 6 months after intake (Hoglend and Perry,
1998). The group of other immature defenses (so-called non-
depressive immature defenses) was not related to improvement.
This confirmed the results of Bloch et al. (1993), who found that
these defenses occurred more frequently in a sample of dysthymic
patients compared to patients with panic disorder. Compared
to patients with anxiety disorders, outpatients diagnosed with
depression had significantly lower ODF and a higher proportion
of maladaptive defenses at the beginning of treatment. However,
depressed patients responded better to treatment, with higher
increase in ODF than patients with anxiety disorders had
(Babl et al., 2019).
In studies involving primarily depressed patients, defensive
functioning improved with an increase in ODF during therapy.
This outcome relates to a specific pattern of defense mechanism
evolution, whereby the proportion of high adaptive defenses
increases, and the proportion of maladaptive defenses decreases
(Kneepkens and Oakley, 1996; Akkerman et al., 1999; Drapeau
et al., 2003; Bond and Perry, 2004; Perry and Bond, 2009;
Kramer et al., 2013; Babl et al., 2019), more specifically depressive
defenses (DeFife and Hilsenroth, 2005; Perry et al., 2020). With
other disorders, ODF also significantly increases but alongside
other patterns of defense mechanism evolution (Perry and Bond,
2017). As suggested by Cramer’s (1998) review, these results
should be seen from the vantage point of adaptational processes
that serve an individual’s need for adaptation; defenses may be
understood as an individual’s way of responding to their need
to adapt. In a sample of patients with personality disorders,
although some individuals improved significantly after 1 year of
therapy, the group did not show significant change in defenses
(Perry, 2001). Longer-term treatments are commonly required
to effect significant improvement in defensive functioning. Perry
and Bond (2009) provided preliminary evidence on change in
ODF over 2.5 years of therapy for three cases with different
personality disorder types.
Relatively few studies have directly examined the extent to
which defensive functioning and defense mechanisms predict
outcomes in depressive disorders. In a pilot study of 12 patients
with recurrent major depression, Perry et al. (2020) showed that
the mean percentage score of depressive defenses significantly
decreased after 20 sessions of psychotherapy (mean ES = 0.97)
and improved defensive functioning led to overall mental health
improvement. However, patients had not maintained this result
after 12 months of follow-up. In a sample of young adults with
adjustment disorders (mainly with mixed anxiety and depressive
symptoms), Kramer (2010) showed prior improvement in
defensive functioning mediated change in distress. The short-
term mutability of mature and immature defenses was also
found in cluster C personality disorders treated with cognitive
behavioral therapy (Johansen et al., 2011).
In long-term psychodynamic psychotherapy of a
heterogeneous sample of patients with anxiety, depression,
and personality disorders, Bond and Perry (2004) reported that
defenses accounted for larger outcome-variance change than
initial symptomatic severity did. Moreover, improvement in ODF
score predicted improvement in observer-rated depression, even
after controlling for improvement in distress. A more mature
defensive functioning was highly associated with improvement
in symptom levels and functioning 5 years after intake (Perry
and Bond, 2012). However, these studies considered the outcome
solely from a statistical point of view, which means that they
sought to disprove a negative and state an event probably did
not happen by chance. By contrast, clinical significance seeks
to prove a positive, and state an event genuinely happened (de
Roten and Crettaz von Roten, 2018). Reliance on statistical
change does not directly address whether subjects improved
clinically or recovered.
This paper explores the extent to which defensive functioning
and defense mechanisms predict improvement and recovery
in short-term dynamic psychotherapy for recurrent or chronic
depression. We address whether (a) defensive functioning and
defense mechanisms help improve adaptiveness or maturity with
therapy, (b) defenses and change in defenses are associated with
treatment response and remission, and (c) defenses and change in
defenses are associated with maintenance of treatment response
after 12 months of follow-up.
MATERIALS AND METHODS
Sample
A subsample was selected from a randomized controlled trial on
the efficacy of adjunctive brief psychodynamic psychotherapy in
usual inpatient treatment of depression (de Roten et al., 2017).
For more detail on the design of the study, see Ambresin et al.
(2012). From among the 76 patients in the psychotherapy group
of the main study, 41 were included. Selection criteria required
patients to have completed at least 10 sessions (n = 52), including
two sessions (the second and the penultimate) that were audio
or video recorded. Univariate tests showed that the subsample’s
demographics and clinical variables were not different from those
of the whole sample (see Supplementary Table 1).
To be included in the main study, patients hospitalized in
the university psychiatric hospital had to (a) meet Diagnostic
and Statistical Manual of Mental Disorders IV criteria for
unipolar major depressive episode; (b) be aged 18–65 years,
(c) have a Montgomery–Asberg Depression Rating Scale
(MADRS; Montgomery and Asberg, 1979) score > 18, and
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Age 42.8 (9.5) 45.5 (9.8) 0.393
Gender (female) 13 (68.4%) 14 (63.6%) 0.829
Education (years) 11.0 (3.4) 9.3 (2.3) 0.064
Marital status
Single 3 (15.8%) 4 (18.1%)
Couple 8 (42.1%) 10 (45.5%)
Divorced/widowed 8 (42.1%) 8 (36.4%) 0.877
Chronicity 9 (47.4%) 12 (54.5%) 0.752
Tentamen 11 (57.9%) 8 (36.4%) 0.739
Early onset 6 (31.6%) 7 (37.8%) 0.631
Duration of current episode 82.5 (101.0) 71.1 (79.7) 0.747
Childhood trauma (CTQ) 2.3 (0.4) 2.3 (1.1) 0.962
Length of hospital stay 42.5 (38.1) 45.2 (42.9) 0.829
Statistical tests were t-test or Fisher exact test; CTQ, Childhood Trauma
Questionnaire.
(d) have sufficient command of French. Exclusion criteria
were limited to bipolar disorders, psychotic disorder, and
persistent substance use/abuse that might affect brain function
(memory, level of consciousness, and cognitive abilities) and
impair an individual from participating in and benefiting
from psychotherapy.
Table 1 shows demographic and clinical characteristics of the
responders (n = 19) and non-responders (n = 22). Univariate
comparisons showed no differences. The 16 therapists (10
women and six men) who participated had completed (10
senior therapists) or were in the advanced stage of completing
(six junior therapists) 5 years of psychotherapy training.
The junior and senior therapists had no differences in their
patients’ response and remission rates. They attended a weekly
training seminar dedicated to inpatient brief psychodynamic
psychotherapy (IBPP) for 6 months before they started their
first IBPP sessions with a patient. We monitored for adherence
and competence through weekly individual supervision and
continued participation in the training seminar.
Instruments
Outcome
We used the MADRS, a clinician-rating measure that uses 10
items to provide a sensitive measure of patient change in inpatient
settings. Davidson et al. (1986) demonstrated the construct
validity of MADRS using an inpatient sample.
Research psychologists (master’s level), who were not involved
in the inpatient care and not located in the hospital, administered
the MADRS. Inter-rater reliability was obtained from 15
audiotaped interviews, mean ICC(2,1) = 0.88, range = 0.68–
0.96. In our study, Cronbach’s α = 0.85. Response and remission
were suggested as the most relevant outcome criteria for the
treatment of depression. In line with Riedel et al. (2010), we
defined response a priori as a reduction in symptom severity
of 46% or higher from the baseline score and remission as
a score of 7 or less, based on cut-off scores determined in a
large inpatient population. Nineteen patients (46.3%) responded
positively to treatment.
We also used the Quick Inventory of Depressive
Symptomatology (QIDS-SR16; Corruble et al., 1999), a 16-item
self-report measure, to evaluate depressive symptomatology. In
our study, Cronbach’s α = 0.81. Response corresponded to a
symptom reduction ≥ 50%, and remission to a score of score of
5 or less, according to Rush et al. (2006). Supplementary Table 2
provides the results for this instrument. Nineteen cases were
responders, according to the QIDS-SR16. Thirteen cases (68.4%
of the responders) were responders, according to both MADRS
and QIDS, and six cases were responders in only one measure.
Three cases were responders according to MADRS but not
according to QIDS, and three cases were responders according to
QIDS but not according to MADRS.
Defense Mechanisms
The Defense Mechanism Rating Scales (DMRS; Perry et al., 2004)
is an observer-based method that identifies any of 30 individual
defense mechanisms as they occur in verbatim transcripts
of therapy sessions or interviews. These mechanisms are
hierarchically arranged in seven defense levels (1–7) according
to their adaptiveness, from the least adaptive to the most
adaptive: action, major image distorting, disavowal, minor
image distorting, neurotic, obsessional, and high adaptive. We
added the Psychotic-Level Defense Mechanisms Rating Scale (P-
DMRS; Berney et al., 2014). This eighth defense level includes
six psychotic defense mechanisms (psychotic denial, autistic
withdrawal, distortion, delusional projection, fragmentation, and
concretization). As is the case in the DMRS, each defense of
the P-DMRS is extensively described (i.e., definition, function,
discrimination, and rating) in a manual (Berney et al., 2010). A
detailed presentation of the P-DMRS with clinical examples for
each defense mechanism can be found in Berney et al. (2014).
The first validation was conducted on a sample of 80 patients with
depressive disorder (n = 20), bipolar disorder (n = 20), personality
disorder (n = 20), and schizophrenic disorder (n = 20). The
validation showed that (a) psychotic defenses can be reliably
identified in transcripts of psychotherapy sessions, (b) psychotic
defenses can be present in a wide range of defensive functioning,
and (c) the new scale has psychometric characteristics similar to
those of the other subscales of the DMRS (Berney et al., 2011).
Combinations of defense level scores define mature (high
adaptive defenses, including affiliation, altruism, anticipation,
humor, self-assertion, self-observation, sublimation, and
suppression), intermediate (obsessional and neurotic defenses),
and immature defense category (psychotic, action, major image
distorting, and disavowal defenses). Moreover, the depressive
defense category is comprised of eight immature defenses
(passive–aggressive, acting out, help-rejecting complaining,
projective identification, splitting of self-images, splitting
of others’ images, projection, and devaluation) empirically
associated with depression, whereas non-depressive defenses are
comprised of autistic fantasy, rationalization, denial, idealization,
and omnipotence (Hoglend and Perry, 1998).
Scores represent the relative frequency per defense level and
defense category, culminating in a weighted score, referred to
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as the ODF score—of the relative frequencies of all defense
mechanisms by their level. Level zero has been attributed to
psychotic defenses, making the ODF score comparable to other
studies without considering psychotic level. For the current study,
reliability coefficients on 18 transcripts (22% of the ratings) were
established among four trained raters and yielded satisfactory
results at the level of defense, with ICC(2,1) varying between
0.69 and 0.94 (M = 0.77; SD = 0.12) for the early session and
between 0.71 and 0.95 (M = 0.78; SD = 0.11) for the late session.
At the level of ODF score, ICC(2,1) were higher, with a mean of
0.85 (SD = 0.09).
Treatment
The IBPP is a manualized 12-session psychodynamic
psychotherapy program developed in Lausanne. IBPP is
based on the Psychodynamic Treatment of Depression manual
developed by Busch et al. (2004) to help therapists focalize on
relevant depression topics, as well as on the Brief Psychodynamic
Psychotherapy manual developed by Despland et al. (2010) for
work on transference, personality organization, and conflictual
themes. The initial hypothesis was based on the dynamic
relationship established between a therapist and a patient
during the first three sessions (pre-transference), a patient’s
present crisis, and the dynamics that form the core of a patient’s
depressive episode. Subsequent sessions focus on helping the
patient gain a fuller understanding of the psychological factors
that led to the emergence of depressive symptoms and address
their vulnerability to those dynamics. Final sessions address
the patient’s feelings and fantasies about termination, as well
as the decision regarding a longer term therapy or ongoing
psychiatric treatment if necessary. Treatment integrity was
checked (de Roten et al., 2017).
Procedure and Analysis
All psychotherapy sessions were audio- or videotaped. From
each case, two sessions (the second and the penultimate) were
transcribed, according to the method defined by Mergenthaler
and Stigler (1997). Five fully trained raters carried out DMRS and
P-DMRS ratings. The first author provided initial weekly group-
training sessions that lasted 12 weeks and subsequent calibration
of raters over 3 months.
Analysis was performed using SPSS version 26. Effect sizes
were within-condition, taking the correlation between the pre-
and posttest into account (Morris and DeShon, 2002). We used
linear mixed models (LMM) to study the effect of time, treatment
response, and the interaction (Time × Response), which were
treated as fixed effects for each defense category and each defense
level, with the MADRS score at intake as covariate. Linear
regressions were used to evaluate the relation between defenses
and MADRS at the same session, using forward stepwise selection
due to sample size.
RESULTS
Do Defenses Evolve During the Therapy?
Table 2 shows changes in defensive functioning, defense
categories, and defense levels after the psychotherapy. ODF
TABLE 2 | Change in defenses.
Defenses d 95% CI
LL UL
Overall defensive functioning 0.727 0.348 1.248
Defense categories
Mature 0.510 0.147 1.031
Intermediate 0.405 −0.016 0.859
Immature −0.543 −1.017 −0.134
Depressive −0.559 −1.015 −0.131
Defense levels
High adaptive 0.510 0.147 1.031
Obsessional 0.382 −0.010 0.865
Neurotic 0.116 −0.313 0.533
Minor image-distorting −0.340 −0.803 0.070
Disavowal −0.240 −0.652 0.216
Major image-distorting −0.417 −0.783 0.089
Action −0.146 −0.586 0.281
Psychotic 0.055 −0.381 0.485
Immature category, psychotic + action + major image-distorting + disavowal
levels; CI, confidence interval; LL, lower limit; UL, upper limit.
increased throughout therapy, yielding a large effect size.
Changes in the mature defense category indicated an increase
of mature defensive behaviors in therapy sessions by the end
of therapy, as indicated by a moderate positive effect size.
Immature and depressive defense categories decreased, as shown
by moderate negative effect sizes. Concerning defense levels, the
high adaptive level increased in frequency, as indicated by a
moderate positive effect size.
Do Defenses Predict Response and
Remission?
We first looked at the relation between defenses and depression
in the same session. Depressive symptom severity was not
significantly correlated with depressive defenses (r = 0.083 for
the second session and 0.255 for the penultimate session).
For the eight defensive levels, a forward stepwise regression
showed, for the second session, an adjusted R2 of 0.277, and
three defensive levels included in the final step (obsessional,
narcissistic, and major image distorting), all significant (p = 0.005,
0.011, and 0.011, respectively). For the penultimate session,
the adjusted R2 was 0.092, with only action level included
(p = 0.030).
Relation between defenses and treatment response and
remission is presented in Table 3. Only defense categories
and defense level with significant results are displayed.
LMM provided strong evidence that high adaptive and
psychotic defense levels were associated with the interaction
between time and response, whereas moderate evidence was
found for an association among ODF, immature defense
category, and the interaction between time and response.
Strong evidence for an association among ODF, high
adaptive level, and response was found, whereas moderate
evidence indicated an association between the immature
category, psychotic level, and response. Intermediate and
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TABLE 3 | Relation among defenses and treatment response and remission.
Response Remission
Defenses Estimate p 95% CI Estimate p 95% CI
LL UL LL UL
Overall defensive functioning
Time −0.476 0.000 −0.677 −0.275 −0.457 0.005 −0.765 −0.149
Response −0.489 0.009 −0.852 −0.126 −0.222 0.371 −0.715 0.271
Time × Response 0.348 0.014 0.073 0.622 0.214 0.222 −0.134 0.562
Mature category/high adaptive level
Time −6.521 0.000 −9.165 −3.877 −4.322 0.048 −8.601 −0.043
Response −4.148 0.007 −7.138 −1.159 2.181 0.267 −1.706 6.069
Time × Response 5.857 0.002 2.248 9.467 1.210 0.616 −3.634 6.054
Psychotic level
Time 2.326 0.078 −0.273 4.926 2.067 0.306 −1.960 6.093
Response 4.073 0.026 0.513 7.632 2.603 0.271 −2.087 7.292
Time × Response −4.990 0.007 −8.539 −1.441 −3.098 0.177 −7.656 1.460
Immature category
Time −10.395 0.000 −15.127 −5.662 9.567 0.005 3.141 15.993
Response −9.415 0.020 −17.283 −1.547 4.769 0.347 −5.329 14.866
Time × Response 6.545 0.047 0.084 13.005 −5.229 0.154 −12.503 2.045
Immature defenses include psychotic, action, borderline, and disavowal levels; CI, confidence interval; LL, lower limit; UL, upper limit.
depressive defense categories, as well as neurotic, minor
image-distorting, disavowal, and major image-distorting
defense levels were not significantly related to response or the
interaction between time and response. Figure 1 illustrates
the interaction between response and time by displaying the
increase in ODF associated with response. Figure 2 displays
the decrease in frequency of psychotic defenses associated
with response.
Nine cases (22.0%) were remitted at the end of the
psychotherapy. No defense category or defense level showed
significant results in terms of treatment response or the
interaction of time and response (Time× Response).
FIGURE 1 | Fixed effect plot with 95% CI for the evolution of ODF for
responders and non-responders. Note. ODF, overall defensive functioning;
Resp, responders; Non-Resp, non-responders; Time 1, pretherapy; Time 2,
posttherapy.
FIGURE 2 | Fixed effect plot with 95% CI for the evolution of psychotic level
for responders and non-responders. Note. Resp, responders; Non-Resp,
non-responders; Time 1, pretherapy; Time 2, posttherapy.
Do Defenses Predict Response and
Remission at Follow-Up?
Sixteen cases (39.0%) were responders at 12-month follow-
up. Thirteen cases were also remitters at the end of the
psychotherapy. All significant results for defense categories and
levels are presented in Table 4. Very strong evidence for an
association among ODF, mature defense category, and response
was found, whereas moderate evidence for an association
between the immature defense category and response was found.
Regarding the interaction between time and response, very strong
evidence was found for an association with the mature defense
category, whereas strong evidence for an association with ODF
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TABLE 4 | Relation among defenses and treatment response and remission after 12-month follow-up.
Response Remission
Defenses Estimate p 95% CI Estimate p 95% CI
LL UL LL UL
Overall defensive functioning
Time −0.473 0.001 −0.690 −0.255 −0.499 0.001 −0.779 −0.219
Response −0.627 0.000 −0.995 −0.259 −0.645 0.005 −1.080 −0.209
Time × Response 0.403 0.008 0.111 −0.694 0.381 0.027 0.046 0.716
Mature category/high adaptive level
Time −7.475 0.000 −10.152 −4.798 −7.500 0.000 −11.279 −3.721
Response −6.142 0.000 −9.120 −3.164 −7.162 0.000 −10.610 −3.716
Time × Response 7.925 0.000 4.333 11.517 6.722 0.005 2.196 11.248
Psychotic level
Time 0.888 0.534 −1.984 3.759 2.310 0.191 −1.210 5.830
Response 4.095 0.022 0.623 7.568 4.099 0.051 −0.022 8.222
Time × Response −3.253 0.095 −7.105 0.560 −5.188 0.018 −9.405 −0.972
Immature category
Time 6.913 0.007 2.033 11.792 6.610 0.044 0.179 13.041
Response 10.237 0.014 2.169 18.306 11.978 0.010 2.969 20.987
Time × Response −3.398 0.299 −9.944 3.149 −2.014 0.598 −9.717 5.689
Immature defenses include psychotic, action, borderline, and disavowal levels; CI, confidence interval; LL, lower limit; UL, upper limit.
was found. The immature defense category was not significantly
associated with the interaction of time and response.
At 12-month follow-up, 30.3% (10 out of 33) of patients
were remitted (eight missing values). Only four cases were also
remitters at the end of the treatment.
DISCUSSION
In line with previous research, our study showed that
defensive functioning and high adaptive defenses significantly
increased, while immature defenses decreased over the course of
psychotherapy. Moreover, within the immature defense category,
the group of depressive defenses changed the most (d = 0.56),
which further validates defense mechanisms as relevant and
specific mechanisms of change in psychotherapy for depression.
However, the effect sizes are lower than those that Perry et al.
(2020) found in a sample of patients with recurrent major
depression. Contrary to what was expected, the depressive
defenses did not predict outcomes.
The original contribution of this study concerned the clinical
significance of defenses as predictors of outcomes by examining
how defenses predict treatment response and remission. Results
showed that the categories of mature and immature defenses
predict responses at the end of the treatment and at 12-month
follow-up. The most adaptive levels of defense (high adaptive
and obsessional) and maladaptive (psychotic and action) levels of
defense are related to response and/or interaction between time
and response, as seen at the end of the treatment but not at follow-
up. Finally, defensive functioning and defense mechanisms are
not predictors of remission. These results confirm previous
research findings and extend them to the specific context of
very brief dynamic psychotherapy for recurrently and chronically
depressed inpatients. A great need exists to identify predictors of
treatment response, and these results clearly showed that defense
mechanisms represent a promising approach.
At the end of the treatment, defenses predicted response
but not remission, whereas a stronger effect would have been
expected. This may be due to a lack of statistical power. The rate
of remission was relatively low: 24% at the end of the therapy
and 25% after 12-month follow-up. An alternative explanation is
that the remission rate may be related to the duration and goal
of the treatment. IBPP is only intended as a first step, which
may work as an initial insight facilitating a longer course of
psychotherapy after hospitalization. Within the IBPP, remission
was not a therapeutic objective and mainly extratherapeutic
reasons facilitated it. Results at 12-month follow-up tend to
confirm this hypothesis. After discharge from the hospital,
95% of patients included in this study were in psychotherapy.
Depressive defenses evolved the most during therapy, but they
did not predict response. Thus, change in depressive defenses
cannot be considered as an outcome measure. Drapeau et al.
(2003) showed that changes in defense mechanisms in very short
interventions are likely related to clinical processes reflecting a
state-dependent improvement. Some studies showed change in
defenses not only in psychodynamic psychotherapy but also in
cognitive behavioral therapy (Babl et al., 2019; Perry et al., 2020).
These depressive defenses are particularly sensitive to therapeutic
work done during hospitalization, and therapeutic progress stems
from the goal of the psychotherapy and hospitalization, which
is to reduce patients’ acute states of distress. These defenses
are particularly strained because of the problems these patients
have with recurrent or chronic depression. We may hypothesize
that change in these defenses as a trait change occurs only after
Frontiers in Psychology | www.frontiersin.org 6 March 2021 | Volume 12 | Article 633939
fpsyg-12-633939 March 14, 2021 Time: 17:38 # 7
de Roten et al. Defense Mechanisms and Treatment Response
long-term psychotherapy and the acquisition of adaptive skills
(Johansen et al., 2011), as seen with personality disorders (Perry
and Bond, 2009). Contrary to previous studies, these defenses
were not associated with depression in our sample. This may
be due to the clinical characteristics of our inpatient sample
such as treatment resistance, chronicity, and high comorbidity.
Compared to Perry et al.’s (2020) study on outpatients with
recurrent depression, the proportion of depressive defenses was
higher in our sample at intake (17.1 vs 26.8) and after the
psychotherapy (8.5 vs 20.1).
In line with our previous work (Berney et al., 2011), psychotic
level showed the same inter-rater reliability as the other defense
levels of the DMRS. Measuring psychotic defenses proved a
useful supplementary approach to examining changes in defenses
over the course of psychoanalytic therapies. In our study,
psychotic defense level is the most predictive level of maladaptive
defense related to outcomes. Moreover, if a patient’s psychological
defenses do not evolve during treatment, then an interaction
effect between time and response may occur. Successful therapy
implies a reduction of these defenses from 5 to 2.5%.
Psychotic defenses were present in 54% of the patients. Among
these patients, an examination of their verbatim statements made
it possible to study the context in which psychotic defenses
appeared in our sample. We found that they tend to appear
when the therapeutic interaction is difficult (e.g., when the
therapeutic alliance is strained or when the patient is in crisis for
an extratherapeutic reason). Further research should explore how
patients improve or worsen these defenses seem to be particularly
sensitive to how therapy evolves. Inclusion of psychotic defenses
in the DMRS provides a better account of patients’ defensive
functioning, psychopathologically more valid defensive scores,
and a more complete and valid measure of patients’ progress
through the course of treatment. From a clinical point of
view, training clinicians to detect psychotic defenses as early as
possible seems to be important to being responsive to patients’
levels of functioning.
In our sample, inpatients did not present psychotic symptoms
that would be coded in phenomenological psychiatric diagnoses.
Use of psychotic defenses does not imply the presence of
psychotic symptoms (Berney et al., 2014). Inpatients in our
sample used unconscious psychotic defense mechanisms to
mediate their reaction to emotional conflicts arising from internal
and external stressors. Our results suggest that psychotic defense
mechanisms is important to consider when studying severe
depression in an inpatient setting, alongside its importance
in the study of severe personality, bipolar, paranoiac, and
schizophrenic disorders. Measuring psychotic defense level may
capture psychotic psychological functioning in severely depressed
inpatients presenting with extreme features of depression
reminiscent of the clinical condition formerly known as
melancholia. Patients often intertwine and mobilize individual
psychotic defense mechanisms together. These mechanisms
are difficult to disentangle and often appear in narratives to
various degrees in narratives (see Berney et al., 2009). The
P-DMRS is comprised of six psychotic defense mechanisms:
psychotic denial, autistic withdrawal, distortion, delusional
projection, fragmentation, and concretization. Although our
results provided evidence that supports the measurement of
psychotic level as a whole, below, we provide examples of a
few individual psychotic defense mechanisms to illustrate their
function in session conditions.
One particular difficulty in treating patients with severe
chronic depression is approaching psychic pain and helping
them face the unbearable thoughts that often underlie
depression (Leuzinger-Bohleber et al., 2019). Clinicians
turning their attention to this psychological pain certainly help
patients strengthen the self and regain a sense of self-agency.
However, therapists can be tempted to avoid addressing defense
mechanisms, thereby resounding with their patients’ defense
mechanisms. Defending themselves against the reviviscence of
traumatic internal or external experiences, severely depressed
inpatients can turn mute, cutting themselves off from the
distressing reviviscence that the clinical encounter elicits
(autistic withdrawal). One of the participants reported: “I stand
in calmness, I shut myself, I close the blinds, I’m in the dark
and then, that’s it, I’m fine like this, in the dark. Lying down,
I can spend a fortnight like that in my room.” This excerpt
appeared in the penultimate session when the therapist and
the patient were exploring the patient’s difficulty coming to
therapy: “I did not want to leave my house, I wanted to stay
locked inside the house. . ..” Therapy was close to its end, and
the therapist and the patient were soon to part. The session’s
rhythm was slow, and the patient emitted heavy sighs. The
narrative of the session started with the patient’s daughter
entering a foster home and the difficulty of being separated
from her. The patient could hardly speak, and the therapist
uttered the following words, adopting the patient’s behavior:
“To do nothing, to avoid any tension inside. . . I prefer to lie
down calmly to avoid any tension and pain. . . to be free of
conflicts. . ..” Finally, the patient agreed: “Yes, I. . . I act like this.”
The excerpt above suggests listening to and working through
the psychic pain helped the patient to overcome the flood of
painful parting sensation leading to autistic withdrawal, helping
her access representations of the blunt pain that had hitherto
been indescribable.
Session narratives also suggest that severely depressed
inpatients mobilized distortion, understood as a gross altering
or reshaping of internal or external reality. Inpatients may
modify the representation of reality in a depressive way,
reminding us of Freud’s (1917) “Mourning and Melancholia”
(p. 245): “The [melancholic] patient represents his ego to us as
worthless, incapable of any achievement and morally despicable:
he reproaches himself, vilifies himself and expects to be cast
out and punished.” Freud (1917) qualified this distortion as
“a delusion of (mainly moral) inferiority” (p. 245). In Margo
et al.’s (1993) study on defensive styles, depression severity was
associated with the amount of negatively biased self-perception
in depressed inpatients. As shown in the following example, a
patient used distortion in a similar way when she considered
herself a “crazy depressive.” The patient started the first session
of therapy saying she was an illegal immigrant and condemned
herself as guilty of her brother’s suicide. Later in the session, she
thought of herself as a murderer: “I read books where someone
killed someone. . .. These are the books I am interested in. . .. It gives
me ideas, I could plan a murder.” The therapist voiced the anger
present in the patient and the patient completed the sentence: “. . .
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everything I try to do leads me there, too. . .. Indeed, I am crazy
[mumbling]. I am a crazy depressive.”
Our findings are likely to measure state changes in psychotic
defenses in a way that is similar to depressive defenses throughout
a brief and intensive psychoanalytic therapy during a particular
phase of the overall depressive course, namely, a crisis leading to
hospitalization. Trait changes are likely to need a longer course
of therapy. However, our findings may indicate that a decrease in
psychotic level can be a first therapeutic step; whether this step
occurs by addressing individual defenses or by containing them
is still unknown and remains an open research question.
These results must be interpreted in light of several potential
limitations. The small sample size limits the statistical power
to detect change, meaning that small or medium effects of the
treatment response may have been missed. Only cases with
available recordings of the two sessions were included. The
possibility that this represents a selection bias, in particular
because the management of the recording was left to the therapist,
could not be ruled out. However, we verified that the cases
selected for this study are no different from the other cases
in the research.
The study is heterogeneous in multiple ways. Different
subtypes of depression and comorbidity were included. At
intake, MADRS depression severity scores varied from 17 to
49. Controlling the additional treatment received during the
hospitalization was not possible. Therefore, other unmeasured
variables or variables that could not be included in the model,
due to the sample size, may moderate the link between
defense and outcome.
The short duration of the treatment and follow-up for
problems that tend to be chronic do not reveal whether patients
developed sustained improvement. Outcome measurement tends
to “evaluate a particular moment in time rather than an ongoing
experience” (Bond and Perry, 2004, p. 1666). Further study
should examine longer treatment to improve the understanding
of the mediating role of defensive functioning and defense
mechanisms in therapy response and remission. Finally, change
in defensive functioning was evaluated by comparing ratings of
only two sessions (the second and the penultimate). Previous
research has shown that the rating of more sessions may
give a more representative measure of defensive functioning,
particularly in terms of a relatively stable trait (Perry, 2001).
The assessment of defenses was only done at the beginning
and end of the brief psychodynamic psychotherapy during
hospitalization. Assessing defenses after 12 months of follow-
up, which would have required interviews, was not possible.
Therefore, the extent to which defenses change in the long term
is not known. The study only assessed whether early changes
in defenses predicted symptomatic improvement in our sample
a year later. We did not also have a measure of structural
change at follow-up, which makes interpreting these results
beyond depressive vulnerability impossible, in terms of structural
personality functioning change.
Another limitation is that the study does not address causal
relationships. The psychoanalytic theory is that beneficial
changes in defensive functioning result in symptomatic
improvement. However, changes in defensive functioning and
improvement of symptoms might be the effects of some other
sort of therapeutic process, such as increases in attachment
security due to a good therapeutic relationship. Improvement
in defensive functioning could be a function of a common
factor (e.g., the therapeutic alliance) that appears to predict
improvement in all psychotherapeutic approaches.
This study complements previous work on how defenses
predict outcomes in depressive disorders by examining the
clinical significance of the results and by including psychotic
defenses. As expected, ODF and specific low- and high-
adaptive levels of defense changed during short psychodynamic
psychotherapy and predicted treatment response. We showed
that the addition of psychotic defenses allows a better prediction
of the treatment response. As Babl et al. (2019) showed,
future research must measure defensive functioning and defense
mechanisms longitudinally to disentangle within- and between-
patient effects of defenses and to achieve unbiased estimates that
are more robust.
DATA AVAILABILITY STATEMENT
The data analyzed in this study are subject to the following
licenses/restrictions: Data are only available for the first author
and the third author (the statistician). Requests to access these
datasets should be directed to yves.deroten@chuv.ch.
ETHICS STATEMENT
The studies involving human participants were reviewed and
approved by University of Lausanne Ethical Committee (April
12, 2010). The patients/participants provided their written
informed consent to participate in this study.
AUTHOR CONTRIBUTIONS
YR designed the study, collected and coded the data, interpreted
the results, and wrote the manuscript. SD coded the data
and wrote the manuscript. FC did the statistical analysis and
supported the interpretation of the results. J-ND designed
the study and supported the interpretation of the results.
GA designed the study, collected the data, and wrote the
manuscript. All authors contributed to the article and approved
the submitted version.
FUNDING
This work was supported by the Swiss National Science
Foundation (Grant 135098).
SUPPLEMENTARY MATERIAL
The Supplementary Material for this article can be found online
at: https://www.frontiersin.org/articles/10.3389/fpsyg.2021.
633939/full#supplementary-material
Frontiers in Psychology | www.frontiersin.org 8 March 2021 | Volume 12 | Article 633939
fpsyg-12-633939 March 14, 2021 Time: 17:38 # 9
de Roten et al. Defense Mechanisms and Treatment Response
REFERENCES
Akkerman, K., Lewin, T., and Carr, V. (1999). Long-term changes in defense style
among patients recovering from major depression. J. Nerv. Ment. Dis. 187,
80–87. doi: 10.1097/00005053-199902000-00003
Ambresin, G., Despland, J.-N., Preisig, M., and de Roten, Y. (2012).
Efficacy of an adjunctive brief psychodynamic psychotherapy to usual
inpatient treatment of depression: rationale and design of a randomized
controlled trial. BMC Psychiatry 12:182. doi: 10.1186/1471-244X-
12-182
Babl, A., Grosse Holforth, M., Perry, J. C., Schneider, N., Domman, E., Heer, S.,
et al. (2019). Comparison and change of defense mechanisms over the course of
psychotherapy in patients with depression or anxiety disorder: evidence from a
randomized controlled trial. J. Affect. Disord. 252, 212–220. doi: 10.1016/j.jad.
2019.04.021
Berney, S., Constantinides, P., de Roten, Y., Kramer, U., Beretta, V., Beck, S., et al.
(2011). Validation of the Psychotic Defense Mechanisms Rating Scale–Lausanne
Montreal (P-DMRS-LM) [Paper presention]. Bern: Society for Psychotherapy
Research Annual International Meeting.
Berney, S., de Roten, Y., Beretta, V., Kramer, U., and Despland, J.-N. (2014).
Identifying psychotic defenses in clinical interview. J. Clin. Psychol. 70, 428–439.
doi: 10.1002/jclp.22087
Berney, S., de Roten, Y., Beretta, V., Kramer, U., Despland, J.-N., Constantinides,
P., et al. (2010). Psychotic Defense Mechanisms Rating Scale Lausanne-
Montreal [Unpublished Manuscript]. London: University Institute for
Psychotherapy.
Berney, S., de Roten, Y., Soderström, D., and Despland, J. -N. (2009). L’étude
des mécanismes de défenses psychotiques: un outil pour la recherche
en psychothérapie. Psychothérapies 29, 133–144. doi: 10.3917/psys.093.
0133
Bloch, A. L., Shear, M. K., Markowitz, J. C., Leon, A. C., and Perry, J. C. (1993).
An empirical study of defense mechanisms in dysthymia. Am. J. Psychiatry 150,
1194–1198. doi: 10.1176/ajp.150.8.1194
Bond, M., and Perry, J. C. (2004). Long-term changes in defense styles
with psychodynamic psychotherapy for depressive, anxiety and personality
disorders. Am. J. Psychother. 161, 1665–1671. doi: 10.1176/appi.ajp.161.
9.1665
Busch, F., Rudden, M., and Shapiro, T. (2004). Psychodynamic
Treatment of Depression. Washington, DC: American Psychiatric
Publishing.
Calati, R., Oasi, O., De Ronchi, D., and Serretti, A. (2010). The use of the defence
style questionnaire in major depressive and panic disorders: a comprehensive
meta-analyis. Psychol. Psychother. Theory Res. Pract. 83, 1–13. doi: 10.1348/
147608309X464206
Corruble, E., Legrand, J. M., Duret, C., Charles, G., and Guelfi, J. D. (1999). IDS-C
and IDS-sr: psychometric properties in depressed inpatients. J. Affect. Disord.
56, 95–101. doi: 10.1016/S0165-0327(99)00055-5
Cramer, P. (1998). Defensiveness and defense mechanisms. J. Pers. 66, 879–894.
doi: 10.1111/1467-6494.00035
Davidson, J., Turnbull, C. D., Strickland, R., Miller, R., and Graves, K.
(1986). The Montgomery-Åsberg depression scale: reliability and validity.
Acta Psychiatr. Scand. 73, 544–548. doi: 10.1111/j.1600-0447.1986.tb
02723.x
de Roten, Y., Ambresin, G., Herrera, F., Ortega, D., Preisig, M., and Despland,
J.-N. (2017). Efficacy of an adjunctive brief psychodynamic psychotherapy
to usual inpatient treatment of depression: results of a randomized
controlled trial. J. Affect. Disord. 209, 105–113. doi: 10.1016/j.jad.2016.
11.013
de Roten, Y., and Crettaz von Roten, F. (2018). Comment lire les résultats
de recherche en psychothérapie : petit guide de survie [How to read
psychotherapy research results: a brief survival guide]. Rev. Francophone Clin.
Comportementale Cogn. 23, 10–22.
DeFife, J. A., and Hilsenroth, M. J. (2005). Clinical utility of the Defensive
Functioning Scale in the assessment of depression. J. Nerv. Ment. Dis. 193,
176–182. doi: 10.1097/01.nmd.0000154839.43440.35
Despland, J.-N., Michel, L., and de Roten, Y. (2010). Intervention
Psychodynamique Brève [Brief Psychodynamic Intervention]. Amsterdam:
Elsevier-Masson.
Drapeau, M., de Roten, Y., Perry, J. C., and Despland, J.-N. (2003). A study of
stability and change in defense mechanisms during a brief psychodynamic
investigation. J. Nerv. Ment. Dis. 191, 496–502. doi: 10.1097/01.nmd.
0000082210.76762.ec
Freud, S. (1917). Mourning and melancholia. Stand. Ed. Complete Psychol. Works
Sigmund Freud 16, 237–258.
Hoglend, P., and Perry, J. C. (1998). Defensive functioning predicts improvement
in major depressive episodes. J. Nerv. Ment. Dis. 186, 238–243. doi: 10.1097/
00005053-199804000-00006
Johansen, P. O., Krebs, T. S., Svartberg, M., Stiles, T. C., and Holen, A. (2011).
Change in defense mechanisms during short-term dynamic and cognitive
therapy in patients with cluster C personality disorders. J. Nerv. Ment. Dis. 199,
712–715. doi: 10.1097/NMD.0b013e318229d6a7
Kneepkens, R. G., and Oakley, L. D. (1996). Rapid improvement in the
defense style of depressed woman and men. J. Nerv. Ment. Dis. 184,
358–361.
Kramer, U. (2010). Defense and coping in bipolar affective disorder: stability and
change of adaptational processes. Br. J. Clin. Psychol. 49, 291–306. doi: 10.1348/
014466509X457397
Kramer, U., de Roten, Y., Perry, J. C., and Despland, J.-N. (2013). Change in
defense mechanisms and coping patterns during the course of 2-year-long
psychotherapy and psychoanalysis for recurrent depression: a pilot study of
a randomized controlled trial. J. Nerv. Ment. Dis. 201, 614–620. doi: 10.1097/
NMD.0b013e3182982982
Leuzinger-Bohleber, M., Kaufhold, J., Kallenbach, L., Negele, A., Ernst, M., Keller,
W., et al. (2019). How to measure sustained psychic transformations in long-
term treatments of chronically depressed patients: symptomatic and structural
changes in the LAC Depression Study of the outcome of cognitive-behavioural
and psychoanalytic long-term treatments. Int. J. Psychoanal. 100, 99–127. doi:
10.1080/00207578.2018.1533377
Margo, G. M., Greenberg, R. P., Fisher, S., and Dewan, M. (1993). A direct
comparison of the defense mechanisms of nondepressed people and depressed
psychiatric inpatients. Compr. Psychiatry 34, 65–69. doi: 10.1016/0010-
440X(93)90038-6
Mergenthaler, E., and Stigler, M. (1997). Règles de transcription pour la
recherche en psychothérapie [Transribing rules for psychotherapy research].
Psychothérapies 17, 97–103.
Montgomery, S. A., and Asberg, M. (1979). A new depression scale designed to
be sensitive to change. Br. J. Psychiatry 134, 382–389. doi: 10.1192/bjp.134.
4.382
Morris, S. B., and DeShon, R. P. (2002). Combining effect size estimates in meta-
analysis with repeated measures and independent-groups designs. Psychol.
Methods 7, 105–125. doi: 10.1037/1082-989x.7.1.105
Perry, J. C. (2001). A pilot study of defenses in adults with personality
disorder. J. Nerv. Ment. Dis. 189, 651–660. doi: 10.1097/00005053-200110000-
00001
Perry, J. C., Banon, E., and Bond, M. (2020). Change in defense mechanisms and
depression in a pilot study of antidepressive medication plus 20 sessions of
psychotherapy for recurrent major depression. J. Nerv. Ment. Dis. 208, 261–268.
doi: 10.1097/NMD.0000000000001112
Perry, J. C., and Bond, M. (2009). The sequence of recovery in long-term
dynamic psychotherapy. J. Nerv. Ment. Dis. 197, 930–937. doi: 10.1097/NMD.
0b013e3181c29a0f
Perry, J. C., and Bond, M. (2012). Change in defense mechanisms during long-term
dynamic psychotherapy and five-year outcome. Am. J. Psychiatry 169, 916–925.
doi: 10.1176/appi.ajp.2012.11091403
Perry, J. C., and Bond, M. (2017). Addressing defenses in psychotherapy to improve
adaptation. Psychoanal. Inq. 37, 153–166. doi: 10.1080/07351690.2017.12
85185
Perry, J. C., Guelfi, J.-D., Despland, J.-N., and Hanin, B. (2004). Echelles
D’évaluation Des Mécanismes De Défense [Defense Mechanisms Rating Scales].
Paris: Masson.
Frontiers in Psychology | www.frontiersin.org 9 March 2021 | Volume 12 | Article 633939
fpsyg-12-633939 March 14, 2021 Time: 17:38 # 10
de Roten et al. Defense Mechanisms and Treatment Response
Riedel, M., Moller, H. J., Obermeier, M., Schennach-Wolff, R., Bauer, M., Adli, M.,
et al. (2010). Response and remission criteria in major depression–a validation
of current practice. J. Psychiatr. Res. 44, 1063–1068. doi: 10.1016/j.jpsychires.
2010.03.006
Rush, A. J., Bernstein, I. H., Trivedi, M. H., Carmody, T. J., Wisniewski, S.,
Mundt, J. C., et al. (2006). An evaluation of the quick inventory of depressive
symptomatology and the hamilton rating scale for depression: a sequenced
treatment alternatives to relieve depression trial report. Biol. Psychiatry 59,
493–501. doi: 10.1016/j.biopsych.2005.08.022
Vaillant, G. E. (1986). Empirical Studies of Ego Mechanisms of Defense. Washington,
DC: American Psychiatric Press.
Conflict of Interest: The authors declare that the research was conducted in the
absence of any commercial or financial relationships that could be construed as a
potential conflict of interest.
Copyright © 2021 de Roten, Djillali, Crettaz von Roten, Despland and Ambresin.
This is an open-access article distributed under the terms of the Creative Commons
Attribution License (CC BY). The use, distribution or reproduction in other forums
is permitted, provided the original author(s) and the copyright owner(s) are credited
and that the original publication in this journal is cited, in accordance with accepted
academic practice. No use, distribution or reproduction is permitted which does not
comply with these terms.
Frontiers in Psychology | www.frontiersin.org 10 March 2021 | Volume 12 | Article 633939
